So did a little reading on NVAX and they got $179M
Post# of 36537
(Total Views: 334)
Posted On: 05/16/2020 9:47:43 PM
So did a little reading on NVAX and they got $179M from BARDA back in 2011 for their influenza vaccine development. In Sep 2016 the PH3 trial failed and they dropped 84% ($45B to $7B MktCap). No wonder they had to go to CEPI for more funding...
https://www.cnbc.com/2016/09/16/novavax-plung...grade.html
https://www.cnbc.com/2016/09/16/novavax-plung...grade.html
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼